Literature DB >> 1309372

Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh.

J D Clemens1, R L Ward, M R Rao, D A Sack, D R Knowlton, F P van Loon, S Huda, M McNeal, F Ahmed, G Schiff.   

Abstract

A case-control study was conducted among children and adult women in rural Bangladesh to evaluate whether serologic immunity to rotavirus was associated with a lower risk of rotavirus diarrhea of sufficient severity to cause patients to seek medical care. Acute-phase sera from 219 cases of rotavirus diarrhea, detected among patients treated in three diarrheal treatment centers, were compared with sera from 477 contemporaneously selected community controls. Overall, serum IgG antirotavirus antibody titers were nearly one-fourth as high in cases as in controls (107 vs. 417 units/ml; P less than .001). Among persons aged greater than or equal to 8 months, in whom titers of maternal antirotavirus antibodies should have been negligible, even the lowest range of detectable titers (100-200 units/ml) was associated with a substantial (75%, P less than .05) reduction of the risk of rotavirus diarrhea. We conclude that titers of serum IgG antirotavirus antibodies induced by earlier infection were inversely related to the risk of clinically significant rotavirus diarrhea.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309372     DOI: 10.1093/infdis/165.1.161

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Rotavirus-specific T-cell responses in young prospectively followed-up children.

Authors:  M Mäkelä; J Marttila; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

2.  Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.

Authors:  Robin M Kaufhold; Jodie A Field; Michael J Caulfield; Su Wang; Heather Joseph; Melissa A Wooters; Tina Green; H Fred Clark; David Krah; Jeffrey G Smith
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Immune response of children who develop persistent diarrhea following rotavirus infection.

Authors:  T Azim; S M Ahmad; M S Sarker; L E Unicomb; S De; J D Hamadani; M A Salam; M A Wahed; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 4.  Rotavirus vaccines: an overview.

Authors:  K Midthun; A Z Kapikian
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Authors:  J Xu; P Dennehy; H Keyserling; L E Westerman; Y Wang; R C Holman; J R Gentsch; R I Glass; B Jiang
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

6.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.

Authors:  Carl D Kirkwood; Karen Boniface; Simone Richardson; Zenobia F Taraporewala; John T Patton; Ruth F Bishop
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

8.  Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.

Authors:  S Johnson; W D Sypura; D N Gerding; S L Ewing; E N Janoff
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.

Authors:  John L VanCott; Anne E Prada; Monica M McNeal; Susan C Stone; Mitali Basu; Bert Huffer; Kristi L Smiley; Mingyuan Shao; Judy A Bean; John D Clements; Anthony H-C Choi; Richard L Ward
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Why does the world need another rotavirus vaccine?

Authors:  Richard L Ward; Monica M McNeal; A Duncan Steele
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.